{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:03:55Z","timestamp":1794589435046,"version":"4.9.1"},"publisher-location":"Cham","reference-count":174,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030055417","type":"print"},{"value":"9783030055424","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-030-05542-4_1","type":"book-chapter","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T02:38:30Z","timestamp":1549939110000},"page":"1-28","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The Potential of \u2018Omics to Link Lipid Metabolism and Genetic and Comorbidity Risk Factors of Alzheimer\u2019s Disease in African Americans"],"prefix":"10.1007","author":[{"given":"Kaitlyn E.","family":"Stepler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e3 A. S.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,13]]},"reference":[{"key":"1_CR1","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jalz.2018.02.001","volume":"14","author":"Alzheimer\u2019s Association","year":"2018","unstructured":"Alzheimer\u2019s Association (2018) 2018 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 14:367\u2013429","journal-title":"Alzheimers Dement"},{"key":"1_CR2","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1377\/hlthaff.2013.1353","volume":"33","author":"LL Barnes","year":"2014","unstructured":"Barnes LL, Bennett DA (2014) Alzheimer\u2019s disease in African Americans: risk factors and challenges for the future. Health Aff (Millwood) 33:580\u2013586","journal-title":"Health Aff (Millwood)"},{"key":"1_CR3","doi-asserted-by":"publisher","DOI":"10.3768\/rtipress.2014.RR.0024.1412","volume-title":"Racial and ethnic disparities among individuals with Alzheimer\u2019s disease in the United States: a literature review","author":"L Lines","year":"2014","unstructured":"Lines L, Sherif NA, Wiener J (2014) Racial and ethnic disparities among individuals with Alzheimer\u2019s disease in the United States: a literature review. RTI Press, Research Triangle Park, NC. https:\/\/pdfs.semanticscholar.org\/7ed5\/b9ed14cd3e002df546134e76766d01c5c4aa.pdf"},{"issue":"1","key":"1_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jalz.2018.06.3063","volume":"15","author":"Kevin A. Matthews","year":"2019","unstructured":"Matthews KA, Xu W, Gaglioti AH, Holt JB, Croft JB, Mack D et al (2018) Racial and ethnic estimates of Alzheimer\u2019s disease and related dementias in the United States (2015\u20132060) in adults aged \u226565 years. Alzheimers Dement. https:\/\/doi.org\/10.1016\/j.jalz.2018.06.3063 [Epub ahead of print]","journal-title":"Alzheimer's & Dementia"},{"key":"1_CR5","doi-asserted-by":"publisher","first-page":"607","DOI":"10.2174\/1567205012666150701102445","volume":"12","author":"RF Gottesman","year":"2015","unstructured":"Gottesman RF, Fornage M, Knopman DS, Mosley TH (2015) Brain aging in African-Americans: the atherosclerosis risk in communities (ARIC) experience. Curr Alzheimer Res 12:607\u2013613","journal-title":"Curr Alzheimer Res"},{"key":"1_CR6","volume-title":"Critical perspectives on racial and ethnic differences in health in late life","author":"JJ Manly","year":"2004","unstructured":"Manly JJ, Mayeux R (2004) Ethnic differences in dementia and Alzheimer\u2019s disease. In: Anderson NB, Bulatao RA, Cohen B (eds) Critical perspectives on racial and ethnic differences in health in late life. National Academies Press, Washington, DC. ASIN: B00FBZPHCU"},{"key":"1_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jalz.2016.06.2360","volume":"13","author":"KM Mehta","year":"2017","unstructured":"Mehta KM, Yeo GW (2017) Systematic review of dementia prevalence and incidence in United States race\/ethnic populations. Alzheimers Dement 13:72\u201383","journal-title":"Alzheimers Dement"},{"key":"1_CR8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jalz.2017.02.001","volume":"13","author":"Alzheimer\u2019s Association","year":"2017","unstructured":"Alzheimer\u2019s Association (2017) Alzheimer\u2019s disease facts and figures. Alzheimers Dement 13:325\u2013373","journal-title":"Alzheimers Dement"},{"key":"1_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/WAD.0b013e318211c6c9","volume":"25","author":"AL Chin","year":"2011","unstructured":"Chin AL, Negash S, Hamilton R (2011) Diversity and disparity in dementia: the impact of ethnoracial differences in Alzheimer disease. Alzheimer Dis Assoc Disord 25:187\u2013195","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1_CR10","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jalz.2015.12.007","volume":"12","author":"ER Mayeda","year":"2015","unstructured":"Mayeda ER, Glymour MM, Quesenberry CP, Whitmer RA (2015) Inequalities in dementia incidence between six racial and ethnic groups over 14 years. Alzheimers Dement 12:216\u2013224","journal-title":"Alzheimers Dement"},{"issue":"4","key":"1_CR11","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.jnma.2017.06.007","volume":"110","author":"SL Burke","year":"2017","unstructured":"Burke SL, Cadet T, Maddux M (2017) Chronic health illnesses as predictors of mild cognitive impairment among African American older adults. J Natl Med Assoc 110(4):314\u2013325","journal-title":"J Natl Med Assoc"},{"key":"1_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.amjopharm.2012.09.002","volume":"10","author":"AM Gilligan","year":"2012","unstructured":"Gilligan AM, Malone DC, Warholak TL, Armstrong EP (2012) Racial and ethnic disparities in Alzheimer\u2019s disease pharmacotherapy exposure: an analysis across four state Medicaid populations. Am J Geriatr Pharmacother 10:303\u2013312","journal-title":"Am J Geriatr Pharmacother"},{"key":"1_CR13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s12264-013-1410-3","volume":"30","author":"Q Liu","year":"2014","unstructured":"Liu Q, Zhang J (2014) Lipid metabolism in Alzheimer\u2019s disease. Neurosci Bull 30:331\u2013345","journal-title":"Neurosci Bull"},{"key":"1_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1749-6632.2012.06513.x","volume":"1259","author":"P Gamba","year":"2012","unstructured":"Gamba P, Testa G, Sottero B, Gargiulo S, Poli G, Leonarduzzi G (2012) The link between altered cholesterol metabolism and Alzheimer\u2019s disease. Ann N Y Acad Sci 1259:54\u201364","journal-title":"Ann N Y Acad Sci"},{"key":"1_CR15","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1111\/j.1471-4159.2009.06408.x","volume":"111","author":"IJ Martins","year":"2009","unstructured":"Martins IJ, Berger T, Sharman MJ, Verdile G, Fuller SJ, Martins RN (2009) Cholesterol metabolism and transport in the pathogenesis of Alzheimer\u2019s disease. J Neurochem 111:1275\u20131308","journal-title":"J Neurochem"},{"key":"1_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3233\/JAD-160169","volume":"53","author":"F Gaamouch El","year":"2016","unstructured":"El Gaamouch F, Jing P, Xia J, Cai D (2016) Alzheimer\u2019s disease risk genes and lipid regulators. J Alzheimers Dis 53:15\u201329","journal-title":"J Alzheimers Dis"},{"key":"1_CR17","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1749-6632.2002.tb04839.x","volume":"977","author":"M Burns","year":"2002","unstructured":"Burns M, Duff K (2002) Cholesterol in Alzheimer\u2019s disease and tauopathy. Ann N Y Acad Sci 977:367\u2013375","journal-title":"Ann N Y Acad Sci"},{"key":"1_CR18","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3389\/fnagi.2015.00199","volume":"7","author":"N Sato","year":"2015","unstructured":"Sato N, Morishita R (2015) The roles of lipid and glucose metabolism in modulation of \u03b2-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer disease. Front Aging Neurosci 7:199. https:\/\/doi.org\/10.3389\/fnagi.2015.00199","journal-title":"Front Aging Neurosci"},{"key":"1_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.5772\/64757","volume-title":"Update on dementia","author":"M Torres","year":"2016","unstructured":"Torres M, Busquets X, Escrib\u00e1 PV (2016) Brain lipids in the pathophysiology and treatment of Alzheimer\u2019s disease. In: Moretti DV (ed) Update on dementia. InTech, Rijeka, pp 127\u2013167. https:\/\/doi.org\/10.5772\/64757"},{"key":"1_CR20","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.jalz.2017.01.008","volume":"13","author":"MW Wong","year":"2017","unstructured":"Wong MW, Braidy N, Poljak A, Pickford R, Thambisetty M, Sachdev PS (2017) Dysregulation of lipids in Alzheimer\u2019s disease and their role as potential biomarkers. Alzheimers Dement 13:810\u2013827","journal-title":"Alzheimers Dement"},{"key":"1_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/01.SMJ.0000077061.01235.42","volume":"97","author":"E Zamrini","year":"2004","unstructured":"Zamrini E, Parrish JA, Parsons D, Harrell LE (2004) Medical comorbidity in black and white patients with Alzheimer\u2019s disease. South Med J 97:2\u20136","journal-title":"South Med J"},{"key":"1_CR22","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1212\/WNL.0000000000001834","volume":"85","author":"LL Barnes","year":"2015","unstructured":"Barnes LL, Leurgans S, Aggarwal NT, Shah RC, Arvanitakis Z, James BD et al (2015) Mixed pathology is more likely in black than white decedents with Alzheimer dementia. Neurology 85:528\u2013534","journal-title":"Neurology"},{"key":"1_CR23","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1001\/jama.2017.3090","volume":"317","author":"RF Gottesman","year":"2017","unstructured":"Gottesman RF, Schneider AC, Zhou Y, Coresh J, Green E, Gupta N et al (2017) Association between midlife vascular risk factors and estimated brain amyloid deposition. JAMA 317:1443\u20131450","journal-title":"JAMA"},{"key":"1_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1001\/archneur.63.1.87","volume":"63","author":"CH Wilkins","year":"2006","unstructured":"Wilkins CH, Grant EA, Schmitt SE, McKeel DW, Morris JC (2006) The neuropathology of Alzheimer disease in African American and white individuals. Arch Neurol 63:87\u201390","journal-title":"Arch Neurol"},{"key":"1_CR25","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.jalz.2016.03.004","volume":"12","author":"NR Graff-Radford","year":"2016","unstructured":"Graff-Radford NR, Besser LM, Crook JE, Kukull WA, Dickson DW (2016) Neuropathological differences by race from the National Alzheimer\u2019s coordinating center. Alzheimers Dement 12:669\u2013677","journal-title":"Alzheimers Dement"},{"key":"1_CR26","first-page":"S39","volume":"43","author":"JA Mortimer","year":"1993","unstructured":"Mortimer JA, Graves AB (1993) Education and other socioeconomic determinants of dementia and Alzheimer\u2019s disease. Neurology 43:S39\u2013S44","journal-title":"Neurology"},{"key":"1_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/01.wad.0000201854.62116.d7","volume":"20","author":"AR Borenstein","year":"2006","unstructured":"Borenstein AR, Copenhaver CI, Mortimer JA (2006) Early-life risk factors for Alzheimer\u2019s disease. Alzheimer Dis Assoc Disord 20:63\u201372","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ebiom.2018.01.021","volume":"28","author":"J Ramos-Cejudo","year":"2018","unstructured":"Ramos-Cejudo J, Wisniewski T, Marmar C, Zetterberg H, Blennow K, de Leon MJ et al (2018) Traumatic brain injury and Alzheimer\u2019s disease: the cerebrovascular link. EBioMedicine 28:21\u201330","journal-title":"EBioMedicine"},{"key":"1_CR29","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1001\/archneur.60.12.1707","volume":"60","author":"LS Honig","year":"2003","unstructured":"Honig LS, Tang MX, Albert S, Costa R, Luchsinger J, Manly J et\u00a0al (2003) Stroke and the risk of Alzheimer disease. Arch Neurol 60:1707\u20131712","journal-title":"Arch Neurol"},{"key":"1_CR30","doi-asserted-by":"publisher","first-page":"282","DOI":"10.14336\/AD.2014.002","volume":"6","author":"S Chakrabarti","year":"2015","unstructured":"Chakrabarti S, Khemka VK, Banerjee A, Chatterjee G, Ganguly A, Biswas A (2015) Metabolic risk factors of sporadic Alzheimer\u2019s disease: implications in the pathology, pathogenesis and treatment. Aging Dis 6:282\u2013299","journal-title":"Aging Dis"},{"key":"1_CR31","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1212\/WNL.0b013e31822e145d","volume":"77","author":"T Matsuzaki","year":"2011","unstructured":"Matsuzaki T, Sasaki K, Hata J, Hirakawa Y, Fujimi K, Ninomiya T et al (2011) Association of Alzheimer disease pathology with abnormal lipid metabolism: the Hisayama study. Neurology 77:1068\u20131075","journal-title":"Neurology"},{"issue":"4","key":"1_CR32","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/jnc.14256","volume":"144","author":"CM Nday","year":"2017","unstructured":"Nday CM, Eleftheriadou D, Jackson G (2017) Shared pathological pathways of Alzheimer\u2019s disease with specific comorbidities: current perspectives and interventions. J Neurochem 144(4):360\u2013389","journal-title":"J Neurochem"},{"key":"1_CR33","doi-asserted-by":"publisher","first-page":"e393","DOI":"10.1161\/CIR.0000000000000534","volume":"136","author":"MR Carnethon","year":"2017","unstructured":"Carnethon MR, Pu J, Howard G, Albert MA, Anderson CAM, Bertoni AG et al (2017) Cardiovascular health in African Americans: a scientific statement from the American Heart Association. Circulation 136:e393\u2013e423","journal-title":"Circulation"},{"key":"1_CR34","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/nrn3012","volume":"12","author":"G Paolo Di","year":"2011","unstructured":"Di Paolo G, Kim TW (2011) Linking lipids to Alzheimer\u2019s disease: cholesterol and beyond. Nat Rev Neurosci 12:284\u2013296","journal-title":"Nat Rev Neurosci"},{"key":"1_CR35","unstructured":"Martins IJ (2015) Diabetes and cholesterol dyshomeostasis involve abnormal \u03b1-synuclein and amyloid beta transport in neurodegenerative diseases. Austin Alzheimer\u2019s and Parkinson\u2019s Disease. https:\/\/api.research-repository.uwa.edu.au\/portalfiles\/portal\/17312757\/Full_publication.pdf"},{"key":"1_CR36","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1212\/WNL.54.1.240","volume":"54","author":"RM Evans","year":"2000","unstructured":"Evans RM, Emsley CL, Gao S, Sahota A, Hall KS, Farlow MR et al (2000) Serum cholesterol, APOE genotype, and the risk of Alzheimer\u2019s disease: a population-based study of African Americans. Neurology 54:240\u2013242","journal-title":"Neurology"},{"issue":"12","key":"1_CR37","first-page":"1299","volume":"86","author":"W Xu","year":"2015","unstructured":"Xu W, Tan L, Wang H-F, Jiang T, Tan M-S, Tan L et al (2015) Meta-analysis of modifiable risk factors for Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 86(12):1299\u20131306","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"1_CR38","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jalz.2017.11.002","volume":"14","author":"HM Gonzalez","year":"2017","unstructured":"Gonzalez HM, Tarraf W, Harrison K, Windham BG, Tingle J, Alonso A et al (2017) Midlife cardiovascular health and 20-year cognitive decline: atherosclerosis risk in communities study results. Alzheimers Dement 14(5):579\u2013589","journal-title":"Alzheimers Dement"},{"key":"1_CR39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/jgs.14472","volume":"65","author":"G Howard","year":"2017","unstructured":"Howard G, Safford MM, Moy CS, Howard VJ, Kleindorfer DO, Unverzagt FW et al (2017) Racial differences in the incidence of cardiovascular risk factors in older black and white adults. J Am Geriatr Soc 65:83\u201390","journal-title":"J Am Geriatr Soc"},{"key":"1_CR40","doi-asserted-by":"publisher","first-page":"710486","DOI":"10.1155\/2012\/710486","volume":"2012","author":"CU Osuji","year":"2012","unstructured":"Osuji CU, Omejua EG, Onwubuya EI, Ahaneku GI (2012) Serum lipid profile of newly diagnosed hypertensive patients in Nnewi, south-East Nigeria. Int J Hypertens 2012:710486. https:\/\/doi.org\/10.1155\/2012\/710486","journal-title":"Int J Hypertens"},{"key":"1_CR41","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1474-4422(11)70072-2","volume":"10","author":"DE Barnes","year":"2011","unstructured":"Barnes DE, Yaffe K (2011) The projected effect of risk factor reduction on Alzheimer\u2019s disease prevalence. Lancet Neurol 10:819\u2013828","journal-title":"Lancet Neurol"},{"issue":"6","key":"1_CR42","doi-asserted-by":"publisher","first-page":"e517","DOI":"10.1212\/WNL.0000000000005951","volume":"91","author":"Z Arvanitakis","year":"2018","unstructured":"Arvanitakis Z, Capuano AW, Lamar M, Shah RC, Barnes LL, Bennett DA et al (2018) Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology. Neurology 91(6):e517\u2013e525","journal-title":"Neurology"},{"key":"1_CR43","doi-asserted-by":"crossref","unstructured":"Williamson JW (2018) A randomized trial of intensive versus standard systolic blood pressure control and the risk of mild cognitive impairment and dementia: results from SPRINT MIND. Proceedings of Alzheimer\u2019s Association International Conference 2018, Chicago, IL, USA. ID 27525","DOI":"10.1016\/j.jalz.2018.07.004"},{"key":"1_CR44","doi-asserted-by":"crossref","unstructured":"Nasrallah IM (2018) A randomized trial of intensive versus standard systolic blood pressure control on brain structure: results from SPRINT MIND MRI. Proceedings of Alzheimer\u2019s Association International Conference 2018, Chicago, IL, USA. ID 27526","DOI":"10.1016\/j.jalz.2018.07.005"},{"key":"1_CR45","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1161\/HYPERTENSIONAHA.110.163196","volume":"57","author":"FD Fuchs","year":"2011","unstructured":"Fuchs FD (2011) Why do black Americans have higher prevalence of hypertension? An enigma still unsolved. Hypertension 57:379\u2013380","journal-title":"Hypertension"},{"key":"1_CR46","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/MAJ.0000000000000308","volume":"348","author":"DT Lackland","year":"2014","unstructured":"Lackland DT (2014) Racial differences in hypertension: implications for high blood pressure management. Am J Med Sci 348:135\u2013138","journal-title":"Am J Med Sci"},{"key":"1_CR47","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1001\/jama.291.17.2107","volume":"291","author":"P Muntner","year":"2004","unstructured":"Muntner P, He J, Cutler JA, Wildman RP, Whelton PK (2004) Trends in blood pressure among children and adolescents. JAMA 291:2107\u20132113","journal-title":"JAMA"},{"key":"1_CR48","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1161\/HYPERTENSIONAHA.110.161950","volume":"57","author":"N Redmond","year":"2011","unstructured":"Redmond N, Baer HJ, Hicks LS (2011) Health behaviors and racial disparity in blood pressure control in the National Health and nutrition examination survey. Hypertension 57:383\u2013389","journal-title":"Hypertension"},{"issue":"3","key":"1_CR49","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","volume":"14","author":"SE Arnold","year":"2018","unstructured":"Arnold SE, Arvanitakis Z, Macauley-Rambach SL, Koenig AM, Wang HY, Ahima RS et al (2018) Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat Rev Neurol 14(3):168\u2013181","journal-title":"Nat Rev Neurol"},{"key":"1_CR50","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.2337\/diacare.27.9.2253","volume":"27","author":"G Boden","year":"2004","unstructured":"Boden G, Laakso M (2004) Lipids and glucose in type 2 diabetes: what is the cause and effect? Diabetes Care 27:2253\u20132259","journal-title":"Diabetes Care"},{"key":"1_CR51","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1152\/physrev.00024.2006","volume":"87","author":"DB Savage","year":"2007","unstructured":"Savage DB, Petersen KF, Shulman GI (2007) Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 87:507\u2013520","journal-title":"Physiol Rev"},{"key":"1_CR52","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3233\/JAD-150980","volume":"51","author":"MA Schilling","year":"2016","unstructured":"Schilling MA (2016) Unraveling Alzheimer\u2019s: making sense of the relationship between diabetes and Alzheimer\u2019s disease. J Alzheimers Dis 51:961\u2013977","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1_CR53","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jalz.2018.06.3060","volume":"15","author":"Anna Marseglia","year":"2019","unstructured":"Marseglia A, Fratiglioni L, Kalpouzos G, Wang R, B\u00e4ckman L, Xu W (2018) Prediabetes and diabetes accelerate cognitive decline and predict microvascular lesions: a population-based cohort study. Alzheimers Dement\u00a0Aug 13. doi: 10.1016\/j.jalz.2018.06.3060. [Epub ahead of print]","journal-title":"Alzheimer's & Dementia"},{"key":"1_CR54","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1159\/000324134","volume":"31","author":"D Cheng","year":"2011","unstructured":"Cheng D, Noble J, Tang MX, Schupf N, Mayeux R, Luchsinger JA (2011) Type 2 diabetes and late-onset Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 31:424\u2013430","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1_CR55","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/jgs.13441","volume":"63","author":"KJ Bangen","year":"2015","unstructured":"Bangen KJ, Gu Y, Gross AL, Schneider BC, Skinner JC, Benitez A et al (2015) Relationship between type 2 diabetes mellitus and cognitive change in a multiethnic elderly cohort. J Am Geriatr Soc 63:1075\u20131083","journal-title":"J Am Geriatr Soc"},{"key":"1_CR56","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jalz.2014.03.011","volume":"11","author":"AA Willette","year":"2015","unstructured":"Willette AA, Johnson SC, Birdsill AC, Sager MA, Christian B, Baker LD et al (2015) Insulin resistance predicts brain amyloid deposition in late middle-aged adults. Alzheimers Dement 11:504\u2013510.e1","journal-title":"Alzheimers Dement"},{"key":"1_CR57","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3233\/JAD-170179","volume":"60","author":"MN Pimentel dos Santos Matioli","year":"2017","unstructured":"Pimentel dos Santos Matioli MN, Suemoto CK, Rodriguez RD, Farias DS, da Silva MM, Paraizo Leite RE et al (2017) Diabetes is not associated with Alzheimer\u2019s disease neuropathology. J Alzheimers Dis 60:1035\u20131043","journal-title":"J Alzheimers Dis"},{"key":"1_CR58","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1212\/WNL.49.5.1306","volume":"49","author":"J Heitner","year":"1997","unstructured":"Heitner J, Dickson D (1997) Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects: a retrospective postmortem immunocytochemical and histofluorescent study. Neurology 49:1306\u20131311","journal-title":"Neurology"},{"key":"1_CR59","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1212\/01.wnl.0000247053.45483.4e","volume":"67","author":"Z Arvanitakis","year":"2006","unstructured":"Arvanitakis Z, Schneider JA, Wilson RS, Li Y, Arnold SE, Wang Z et al (2006) Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology 67:1960\u20131965","journal-title":"Neurology"},{"key":"1_CR60","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jalz.2015.12.006","volume":"12","author":"EL Abner","year":"2016","unstructured":"Abner EL, Nelson PT, Kryscio RJ, Schmitt FA, Fardo DW, Woltjer RL et al (2016) Diabetes is associated with cerebrovascular but not Alzheimer\u2019s disease neuropathology. Alzheimers Dement 12:882\u2013889","journal-title":"Alzheimers Dement"},{"key":"1_CR61","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1212\/WNL.0b013e3181f4d7f8","volume":"75","author":"S Ahtiluoto","year":"2010","unstructured":"Ahtiluoto S, Polvikoski T, Peltonen M, Solomon A, Tuomilehto J, Winblad B et al (2010) Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study. Neurology 75:1195\u20131202","journal-title":"Neurology"},{"key":"1_CR62","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1001\/jama.283.17.2253","volume":"283","author":"FL Brancati","year":"2000","unstructured":"Brancati FL, Kao W, Folsom AR, Watson RL, Szklo M (2000) Incident type 2 diabetes mellitus in African American and white adults: the atherosclerosis risk in communities study. JAMA 283:2253\u20132259","journal-title":"JAMA"},{"key":"1_CR63","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1136\/pgmj.2004.028274","volume":"81","author":"M Marshall","year":"2005","unstructured":"Marshall M (2005) Diabetes in African Americans. Postgrad Med J 81:734\u2013740","journal-title":"Postgrad Med J"},{"key":"1_CR64","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1159\/000366506","volume":"43","author":"ER Mayeda","year":"2014","unstructured":"Mayeda ER, Haan MN, Neuhaus J, Yaffe K, Knopman DS, Sharrett AR et al (2014) Type 2 diabetes and cognitive decline over 14 years in middle-aged African Americans and whites: the ARIC brain MRI study. Neuroepidemiology 43:220\u2013227","journal-title":"Neuroepidemiology"},{"key":"1_CR65","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/WAD.0b013e3181a6bed5","volume":"24","author":"Z Arvanitakis","year":"2010","unstructured":"Arvanitakis Z, Bennett DA, Wilson RS, Barnes LL (2010) Diabetes and cognitive systems in older black and white persons. Alzheimer Dis Assoc Disord 24:37\u201342","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"12","key":"1_CR66","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/j.jalz.2018.03.008","volume":"14","author":"Hugh C. Hendrie","year":"2018","unstructured":"Hendrie HC, Zheng M, Lane KA, Ambuehl R, Purnell C, Li S et al (2018) Changes of glucose levels precede dementia in African-Americans with diabetes but not in Caucasians. Alzheimers Dement\u00a014(12):1572-1579","journal-title":"Alzheimer's & Dementia"},{"key":"1_CR67","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jalz.2016.08.017","volume":"13","author":"HC Hendrie","year":"2017","unstructured":"Hendrie HC, Zheng M, Li W, Lane K, Ambuehl R, Purnell C et al (2017) Glucose level decline precedes dementia in elderly African Americans with diabetes. Alzheimers Dement 13:111\u2013118","journal-title":"Alzheimers Dement"},{"key":"1_CR68","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jalz.2017.07.755","volume":"14","author":"MR Azarpazhooh","year":"2017","unstructured":"Azarpazhooh MR, Avan A, Cipriano LE, Munoz DG, Sposato LA, Hachinski V (2017) Concomitant vascular and neurodegenerative pathologies double the risk of dementia. Alzheimers Dement 14:148\u2013156","journal-title":"Alzheimers Dement"},{"key":"1_CR69","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.3233\/JAD-141812","volume":"44","author":"AL Jefferson","year":"2015","unstructured":"Jefferson AL, Hohman TJ, Liu D, Haj-Hassan S, Gifford KA, Benson EM et al (2015) Adverse vascular risk is related to cognitive decline in older adults. J Alzheimers Dis 44:1361\u20131373","journal-title":"J Alzheimers Dis"},{"key":"1_CR70","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1212\/WNL.0b013e318217e7a4","volume":"76","author":"J Li","year":"2011","unstructured":"Li J, Wang YJ, Zhang M, Xu ZQ, Gao CY, Fang CQ et al (2011) Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Neurology 76:1485\u20131491","journal-title":"Neurology"},{"key":"1_CR71","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1093\/brain\/awt188","volume":"136","author":"JB Toledo","year":"2013","unstructured":"Toledo JB, Arnold SE, Raible K, Brettschneider J, Xie SX, Grossman M et al (2013) Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer\u2019s coordinating Centre. Brain 136:2697\u20132706","journal-title":"Brain"},{"key":"1_CR72","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1161\/01.STR.29.12.2656","volume":"29","author":"PB Gorelick","year":"1998","unstructured":"Gorelick PB (1998) Cerebrovascular disease in African Americans. Stroke 29:2656\u20132664","journal-title":"Stroke"},{"key":"1_CR73","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1161\/01.STR.28.1.15","volume":"28","author":"LB Morgenstern","year":"1997","unstructured":"Morgenstern LB, Spears WD, Goff DC, Grotta JC, Nichaman MZ (1997) African Americans and women have the highest stroke mortality in Texas. Stroke 28:15\u201318","journal-title":"Stroke"},{"key":"1_CR74","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0197-4580(00)00236-0","volume":"22","author":"G Sandberg","year":"2001","unstructured":"Sandberg G, Stewart W, Smialek J, Troncoso JC (2001) The prevalence of the neuropathological lesions of Alzheimer\u2019s disease is independent of race and gender. Neurobiol Aging 22:169\u2013175","journal-title":"Neurobiol Aging"},{"key":"1_CR75","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/ana.25189","volume":"83","author":"Z Arvanitakis","year":"2018","unstructured":"Arvanitakis Z, Leurgans SE, Fleischman DA, Schneider JA, Rajan KB, Pruzin JJ et al (2018) Memory complaints, dementia, and neuropathology in older blacks and whites. Ann Neurol 83:718\u2013729","journal-title":"Ann Neurol"},{"issue":"1","key":"1_CR76","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000125","volume":"3","author":"T Raj","year":"2017","unstructured":"Raj T, Chibnik LB, McCabe C, Wong A, Replogle JM, Yu L et al (2017) Genetic architecture of age-related cognitive decline in African Americans. Neurol Genet 3(1):e125. https:\/\/doi.org\/10.1212\/NXG.0000000000000125","journal-title":"Neurol Genet"},{"key":"1_CR77","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.neulet.2007.02.010","volume":"416","author":"FW-D Vri\u00e8ze","year":"2007","unstructured":"Vri\u00e8ze FW-D, Compton D, Womick M, Arepalli S, Adighibe O, Li L et al (2007) ABCA1 polymorphisms and Alzheimer\u2019s disease. Neurosci Lett 416:180\u2013183","journal-title":"Neurosci Lett"},{"key":"1_CR78","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.bbalip.2010.02.010","volume":"1801","author":"R Koldamova","year":"2010","unstructured":"Koldamova R, Fitz NF, Lefterov I (2010) The role of ATP-binding cassette transporter A1 in Alzheimer\u2019s disease and neurodegeneration. Biochim Biophys Acta 1801:824\u2013830","journal-title":"Biochim Biophys Acta"},{"key":"1_CR79","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neulet.2017.11.027","volume":"664","author":"\u00c1 Feh\u00e9r","year":"2018","unstructured":"Feh\u00e9r \u00c1, Giricz Z, Juh\u00e1sz A, P\u00e1k\u00e1ski M, Janka Z, K\u00e1lm\u00e1n J (2018) ABCA1 rs2230805 and rs2230806 common gene variants are associated with Alzheimer\u2019s disease. Neurosci Lett 664:79\u201383","journal-title":"Neurosci Lett"},{"issue":"2","key":"1_CR80","doi-asserted-by":"publisher","first-page":"E27","DOI":"10.3390\/brainsci8020027","volume":"8","author":"T Aikawa","year":"2018","unstructured":"Aikawa T, Holm ML, Kanekiyo T (2018) ABCA7 and pathogenic pathways of Alzheimer\u2019s disease. Brain Sci 8(2):E27. https:\/\/doi.org\/10.3390\/brainsci8020027","journal-title":"Brain Sci"},{"issue":"3","key":"1_CR81","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s12031-018-1045-y","volume":"64","author":"JFF Almeida","year":"2018","unstructured":"Almeida JFF, Dos Santos LR, Trancozo M, de Paula F (2018) Updated meta-analysis of BIN1, CR1, MS4A6A, CLU, and ABCA7 variants in Alzheimer\u2019s disease. J Mol Neurosci 64(3):471\u2013477","journal-title":"J Mol Neurosci"},{"key":"1_CR82","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/ng.803","volume":"43","author":"P Hollingworth","year":"2011","unstructured":"Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM et al (2011) Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease. Nat Genet 43:429\u2013435","journal-title":"Nat Genet"},{"key":"1_CR83","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/ng.801","volume":"43","author":"AC Naj","year":"2011","unstructured":"Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J et\u00a0al (2011) Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease. Nat Genet 43:436\u2013441","journal-title":"Nat Genet"},{"key":"1_CR84","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/S1474-4422(15)00133-7","volume":"14","author":"E Cuyvers","year":"2015","unstructured":"Cuyvers E, De Roeck A, Van den Bossche T, Van Cauwenberghe C, Bettens K, Vermeulen S et al (2015) Mutations in ABCA7 in a Belgian cohort of Alzheimer\u2019s disease patients: a targeted resequencing study. Lancet Neurol 14:814\u2013822","journal-title":"Lancet Neurol"},{"key":"1_CR85","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet 45:1452\u20131458","journal-title":"Nat Genet"},{"issue":"1","key":"1_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087017","volume":"9","author":"Q Zhou","year":"2014","unstructured":"Zhou Q, Zhao F, Lv Z-P, Zheng C-G, Zheng W-D, Sun L et al (2014) Association between APOC1 polymorphism and Alzheimer\u2019s disease: a case-control study and meta-analysis. PLoS One 9(1):e87017. https:\/\/doi.org\/10.1371\/journal.pone.0087017","journal-title":"PLoS One"},{"key":"1_CR87","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1006\/nbdi.2001.0441","volume":"8","author":"C Petit-Turcotte","year":"2001","unstructured":"Petit-Turcotte C, Stohl SM, Beffert U, Cohn JS, Aumont N, Tremblay M et al (2001) Apolipoprotein C-I expression in the brain in Alzheimer\u2019s disease. Neurobiol Dis 8:953\u2013963","journal-title":"Neurobiol Dis"},{"key":"1_CR88","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0304-3940(01)02559-9","volume":"319","author":"C-S Ki","year":"2002","unstructured":"Ki C-S, Na DL, Kim DK, Kim HJ, Kim J-W (2002) Genetic association of an apolipoprotein C-I (APOC1) gene polymorphism with late-onset Alzheimer\u2019s disease. Neurosci Lett 319:75\u201378","journal-title":"Neurosci Lett"},{"key":"1_CR89","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/ajmg.b.10798","volume":"116B","author":"PP Desai","year":"2003","unstructured":"Desai PP, Hendrie HC, Evans RM, Murrell JR, DeKosky ST, Kamboh MI (2003) Genetic variation in apolipoprotein D affects the risk of Alzheimer disease in African-Americans. Am J Med Genet B Neuropsychiatr Genet 116B:98\u2013101","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"4","key":"1_CR90","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.biopsych.2017.03.003","volume":"83","author":"N Zhao","year":"2017","unstructured":"Zhao N, Liu C-C, Qiao W, Bu G (2017) Apolipoprotein E, receptors, and modulation of Alzheimer\u2019s disease. Biol Psychiatry 83(4):347\u2013357","journal-title":"Biol Psychiatry"},{"key":"1_CR91","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1001\/jama.2013.2973","volume":"309","author":"C Reitz","year":"2013","unstructured":"Reitz C, Jun G, Naj A, Rajbhandary R, Vardarajan BN, Wang L-S et al (2013) Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E \u03b54, and the risk of late-onset Alzheimer disease in African Americans. JAMA 309:1483\u20131492","journal-title":"JAMA"},{"key":"1_CR92","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.biopsych.2013.06.003","volume":"75","author":"C Reitz","year":"2014","unstructured":"Reitz C, Mayeux R (2014) Genetics of Alzheimer\u2019s disease in Caribbean Hispanic and African American populations. Biol Psychiatry 75:534\u2013541","journal-title":"Biol Psychiatry"},{"key":"1_CR93","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1001\/jama.2010.574","volume":"303","author":"S Seshadri","year":"2010","unstructured":"Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M et al (2010) Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303:1832\u20131840","journal-title":"JAMA"},{"key":"1_CR94","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ajhg.2008.10.008","volume":"83","author":"L Bertram","year":"2008","unstructured":"Bertram L, Lange C, Mullin K, Parkinson M, Hsiao M, Hogan MF et al (2008) Genome-wide association analysis reveals putative Alzheimer\u2019s disease susceptibility loci in addition to APOE. Am J Hum Genet 83:623\u2013632","journal-title":"Am J Hum Genet"},{"key":"1_CR95","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"J-C Lambert","year":"2009","unstructured":"Lambert J-C, Heath S, Even G, Campion D, Sleegers K, Hiltunen M et al (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease. Nat Genet 41:1094\u20131099","journal-title":"Nat Genet"},{"key":"1_CR96","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML et al (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat Genet 41:1088\u20131093","journal-title":"Nat Genet"},{"key":"1_CR97","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/ng1943","volume":"39","author":"E Rogaeva","year":"2007","unstructured":"Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F et al (2007) The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer\u2019s disease. Nat Genet 39:168\u2013177","journal-title":"Nat Genet"},{"key":"1_CR98","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1001\/archneur.64.4.501","volume":"64","author":"JH Lee","year":"2007","unstructured":"Lee JH, Cheng R, Schupf N, Manly J, Lantigua R, Stern Y et al (2007) The association between genetic variants in SORL1 and Alzheimer\u2019s disease in an urban, multiethnic, community-based cohort. Arch Neurol 64:501\u2013506","journal-title":"Arch Neurol"},{"issue":"1","key":"1_CR99","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13195-016-0222-x","volume":"8","author":"C-T Chou","year":"2016","unstructured":"Chou C-T, Liao Y-C, Lee W-J, Wang S-J, Fuh J-L (2016) SORL1 gene, plasma biomarkers, and the risk of Alzheimer\u2019s disease for the Han Chinese population in Taiwan. Alzheimers Res Ther 8(1):53. https:\/\/doi.org\/10.1186\/s13195-016-0222-x","journal-title":"Alzheimers Res Ther"},{"key":"1_CR100","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1001\/jamaneurol.2015.1700","volume":"72","author":"M Ghani","year":"2015","unstructured":"Ghani M, Reitz C, Cheng R, Vardarajan BN, Jun G, Sato C et al (2015) Association of long runs of homozygosity with Alzheimer disease among African American individuals. JAMA Neurol 72:1313\u20131323","journal-title":"JAMA Neurol"},{"key":"1_CR101","doi-asserted-by":"publisher","first-page":"180.e1","DOI":"10.1016\/j.neurobiolaging.2018.01.018","volume":"66","author":"C Picard","year":"2018","unstructured":"Picard C, Julien C, Frappier J, Miron J, Th\u00e9roux L, Dea D et al (2018) Alterations in cholesterol metabolism-related genes in sporadic Alzheimer\u2019s disease. Neurobiol Aging 66:180.e1\u2013180.e9. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.01.018","journal-title":"Neurobiol Aging"},{"key":"1_CR102","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.neuropharm.2010.01.005","volume":"59","author":"KR Bales","year":"2010","unstructured":"Bales KR (2010) Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer\u2019s disease. Neuropharmacology 59:295\u2013302","journal-title":"Neuropharmacology"},{"key":"1_CR103","doi-asserted-by":"publisher","first-page":"157.e11","DOI":"10.1016\/j.neurobiolaging.2017.11.013","volume":"64","author":"H Girard","year":"2017","unstructured":"Girard H, Potvin O, Nugent S, Dallaire-Theroux C, Cunnane S, Duchesne S (2017) Faster progression from MCI to probable AD for carriers of a single-nucleotide polymorphism associated with type 2 diabetes. Neurobiol Aging 64:157.e11\u2013157.e17. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.11.013","journal-title":"Neurobiol Aging"},{"key":"1_CR104","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0006-8993(96)00183-7","volume":"722","author":"T Pirttila","year":"1996","unstructured":"Pirttila T, Soininen H, Heinonen O, Lehtimaki T, Bogdanovic N, Paljarvi L et al (1996) Apolipoprotein E (apoE) levels in brains from Alzheimer disease patients and controls. Brain Res 722:71\u201377","journal-title":"Brain Res"},{"key":"1_CR105","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.2337\/diabetes.51.4.1256","volume":"51","author":"R Peila","year":"2002","unstructured":"Peila R, Rodriguez BL, Launer LJ (2002) Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia aging study. Diabetes 51:1256\u20131262","journal-title":"Diabetes"},{"key":"1_CR106","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.neuroimage.2017.12.027","volume":"172","author":"F Corlier","year":"2018","unstructured":"Corlier F, Hafzalla G, Faskowitz J, Kuller LH, Becker JT, Lopez OL et al (2018) Systemic inflammation as a predictor of brain aging: contributions of physical activity, metabolic risk, and genetic risk. NeuroImage 172:118\u2013129","journal-title":"NeuroImage"},{"key":"1_CR107","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1212\/01.wnl.0000194507.39504.17","volume":"66","author":"K Hall","year":"2006","unstructured":"Hall K, Murrell J, Ogunniyi A, Deeg M, Baiyewu O, Gao S et al (2006) Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba. Neurology 66:223\u2013227","journal-title":"Neurology"},{"issue":"1","key":"1_CR108","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jalz.2018.08.002","volume":"15","author":"Yen-Feng Lin","year":"2019","unstructured":"Lin Y-F, Smith AV, Aspelund T, Betensky RA, Smoller JW, Gudnason V et al (2018) Genetic overlap between vascular pathologies and Alzheimer\u2019s dementia and potential causal mechanisms. Alzheimers Dement\u00a0Sep 19. doi: 10.1016\/j.jalz.2018.08.002. [Epub ahead of print]","journal-title":"Alzheimer's & Dementia"},{"issue":"3","key":"1_CR109","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000079","volume":"2","author":"HN Cukier","year":"2016","unstructured":"Cukier HN, Kunkle BW, Vardarajan BN, Rolati S, Hamilton-Nelson KL, Kohli MA et al (2016) ABCA7 frameshift deletion associated with Alzheimer disease in African Americans. Neurol Genet 2(3):e79. https:\/\/doi.org\/10.1212\/NXG.0000000000000079","journal-title":"Neurol Genet"},{"key":"1_CR110","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.neulet.2013.09.058","volume":"556","author":"JB Vasquez","year":"2013","unstructured":"Vasquez JB, Fardo DW, Estus S (2013) ABCA7 expression is associated with Alzheimer\u2019s disease polymorphism and disease status. Neurosci Lett 556:58\u201362","journal-title":"Neurosci Lett"},{"key":"1_CR111","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jalz.2015.02.012","volume":"12","author":"TJ Hohman","year":"2016","unstructured":"Hohman TJ, Cooke-Bailey JN, Reitz C, Jun G, Naj A, Beecham GW et al (2016) Global and local ancestry in African-Americans: implications for Alzheimer\u2019s disease risk. Alzheimers Dement 12:233\u2013243","journal-title":"Alzheimers Dement"},{"key":"1_CR112","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.bcp.2013.12.024","volume":"88","author":"C Reitz","year":"2014","unstructured":"Reitz C, Mayeux R (2014) Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol 88:640\u2013651","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"1_CR113","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179677","volume":"12","author":"Z Han","year":"2017","unstructured":"Han Z, Huang H, Gao Y, Huang Q (2017) Functional annotation of Alzheimer\u2019s disease associated loci revealed by GWASs. PLoS One 12(6):e0179677. https:\/\/doi.org\/10.1371\/journal.pone.0179677","journal-title":"PLoS One"},{"key":"1_CR114","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.bbalip.2010.04.005","volume":"1801","author":"L Jones","year":"2010","unstructured":"Jones L, Harold D, Williams J (2010) Genetic evidence for the involvement of lipid metabolism in Alzheimer\u2019s disease. Biochim Biophys Acta 1801:754\u2013761","journal-title":"Biochim Biophys Acta"},{"key":"1_CR115","doi-asserted-by":"publisher","first-page":"13125","DOI":"10.1523\/JNEUROSCI.1937-12.2012","volume":"32","author":"NF Fitz","year":"2012","unstructured":"Fitz NF, Cronican AA, Saleem M, Fauq AH, Chapman R, Lefterov I et al (2012) Abca1 deficiency affects Alzheimer\u2019s disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice. J Neurosci 32:13125\u201313136","journal-title":"J Neurosci"},{"key":"1_CR116","first-page":"671","volume":"118","author":"SE Wahrle","year":"2008","unstructured":"Wahrle SE, Jiang H, Parsadanian M, Kim J, Li A, Knoten A et al (2008) Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. J Clin Invest 118:671\u2013682","journal-title":"J Clin Invest"},{"key":"1_CR117","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/mp.2013.142","volume":"19","author":"D Felsky","year":"2013","unstructured":"Felsky D, Szeszko P, Yu L, Honer WG, De Jager PL, Schneider JA et al (2013) The SORL1 gene and convergent neural risk for Alzheimer\u2019s disease across the human lifespan. Mol Psychiatry 19:1125\u20131132","journal-title":"Mol Psychiatry"},{"issue":"2","key":"1_CR118","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jalz.2017.07.757","volume":"14","author":"MC Power","year":"2017","unstructured":"Power MC, Rawlings A, Sharrett AR, Bandeen-Roche K, Coresh J, Ballantyne CM et al (2017) Association of midlife lipids with 20-year cognitive change: a cohort study. Alzheimers Dement 14(2):167\u2013177","journal-title":"Alzheimers Dement"},{"key":"1_CR119","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.dadm.2018.07.001","volume":"10","author":"M Koch","year":"2018","unstructured":"Koch M, DeKosky ST, Fitzpatrick AL, Furtado JD, Lopez OL, Kuller LH et al (2018) Apolipoproteins and Alzheimer\u2019s pathophysiology. Alzheimer\u2019s Dement (Amst) 10:545. https:\/\/doi.org\/10.1016\/j.dadm.2018.07.001","journal-title":"Alzheimer\u2019s Dement (Amst)"},{"key":"1_CR120","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.neurobiolaging.2013.09.040","volume":"35","author":"TM Hughes","year":"2014","unstructured":"Hughes TM, Lopez OL, Evans RW, Kamboh MI, Williamson JD, Klunk WE et al (2014) Markers of cholesterol transport are associated with amyloid deposition in the brain. Neurobiol Aging 35:802\u2013807","journal-title":"Neurobiol Aging"},{"issue":"1","key":"1_CR121","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13195-017-0276-4","volume":"9","author":"D Chiasserini","year":"2017","unstructured":"Chiasserini D, Biscetti L, Eusebi P, Salvadori N, Frattini G, Simoni S et al (2017) Differential role of CSF fatty acid binding protein 3, \u03b1-synuclein, and Alzheimer\u2019s disease core biomarkers in Lewy body disorders and Alzheimer\u2019s dementia. Alzheimers Res Ther 9(1):52. https:\/\/doi.org\/10.1186\/s13195-017-0276-4","journal-title":"Alzheimers Res Ther"},{"key":"1_CR122","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.trci.2018.01.002","volume":"4","author":"B Krishnan","year":"2018","unstructured":"Krishnan B, Kayed R, Taglialatela G (2018) Elevated phospholipase D isoform 1 in Alzheimer\u2019s disease patients\u2019 hippocampus: relevance to synaptic dysfunction and memory deficits. Alzheimers Dement (N.Y.) 4:89\u2013102","journal-title":"Alzheimers Dement (N.Y.)"},{"key":"1_CR123","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3233\/JAD-170204","volume":"59","author":"SA Ferguson","year":"2017","unstructured":"Ferguson SA, Panos JJ, Sloper D, Varma V (2017) Neurodegenerative markers are increased in postmortem BA21 tissue from African Americans with Alzheimer\u2019s disease. J Alzheimers Dis 59:57\u201366","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"1_CR124","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1074\/mcp.R115.053330","volume":"15","author":"G Moya-Alvarado","year":"2015","unstructured":"Moya-Alvarado G, Gershoni-Emek N, Perlson E, Bronfman FC (2015) Neurodegeneration and Alzheimer\u2019s disease. What can proteomics tell us about the Alzheimer\u2019s brain? Mol Cell Proteomics 15(2):409\u2013425","journal-title":"Mol Cell Proteomics"},{"key":"1_CR125","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-3-319-52479-5_2","volume":"974","author":"RAS Robinson","year":"2017","unstructured":"Robinson RAS, Amin B, Guest PC (2017) Multiplexing biomarker methods, proteomics and considerations for Alzheimer\u2019s disease. Adv Exp Med Biol 974:21\u201348","journal-title":"Adv Exp Med Biol"},{"key":"1_CR126","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1021\/pr3001546","volume":"11","author":"VP Andreev","year":"2012","unstructured":"Andreev VP, Petyuk VA, Brewer HM, Karpievitch YV, Xie F, Clarke J et\u00a0al (2012) Label-free quantitative LC-MS proteomics of Alzheimer\u2019s disease and normally aged human brains. J Proteome Res 11:3053\u20133067","journal-title":"J Proteome Res"},{"issue":"1","key":"1_CR127","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1559-0275-10-5","volume":"10","author":"I Begcevic","year":"2013","unstructured":"Begcevic I, Kosanam H, Martinez-Morillo E, Dimitromanolakis A, Diamandis P, Kuzmanov U et al (2013) Semiquantitative proteomic analysis of human hippocampal tissues from Alzheimer\u2019s disease and age-matched control brains. Clin Proteomics 10(1):5. https:\/\/doi.org\/10.1186\/1559-0275-10-5","journal-title":"Clin Proteomics"},{"key":"1_CR128","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/prca.201400149","volume":"9","author":"AR Evans","year":"2015","unstructured":"Evans AR, Gu L, Guerrero R, Robinson RAS (2015) Global cPILOT analysis of the APP\/PS-1 mouse liver proteome. Proteomics Clin Appl 9:872\u2013884","journal-title":"Proteomics Clin Appl"},{"issue":"6","key":"1_CR129","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179280","volume":"12","author":"C Fania","year":"2017","unstructured":"Fania C, Arosio B, Capitanio D, Torretta E, Gussago C, Ferri E et al (2017) Protein signature in cerebrospinal fluid and serum of Alzheimer\u2019s disease patients: the case of apolipoprotein A-1 proteoforms. PLoS One 12(6):e0179280. https:\/\/doi.org\/10.1371\/journal.pone.0179280","journal-title":"PLoS One"},{"key":"1_CR130","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jalz.2015.11.002","volume":"12","author":"DC Hondius","year":"2016","unstructured":"Hondius DC, van Nierop P, Li KW, Hoozemans JJM, van der Schors RC, van Haastert ES et al (2016) Profiling the human hippocampal proteome at all pathologic stages of Alzheimer\u2019s disease. Alzheimers Dement 12:654\u2013668","journal-title":"Alzheimers Dement"},{"key":"1_CR131","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1373\/clinchem.2005.053090","volume":"51","author":"MF Lopez","year":"2005","unstructured":"Lopez MF, Mikulskis A, Kuzdzal S, Bennett DA, Kelly J, Golenko E et al (2005) High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein\u2013bound mass signatures. Clin Chem 51:1946\u20131954","journal-title":"Clin Chem"},{"key":"1_CR132","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2013.76","volume":"45","author":"A Manavalan","year":"2013","unstructured":"Manavalan A, Mishra M, Feng L, Sze SK, Akatsu H, Heese K (2013) Brain site-specific proteome changes in aging-related dementia. Exp Mol Med 45:e39. https:\/\/doi.org\/10.1038\/emm.2013.76","journal-title":"Exp Mol Med"},{"key":"1_CR133","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jprot.2016.03.022","volume":"139","author":"B Minjarez","year":"2016","unstructured":"Minjarez B, Calderon-Gonzalez KG, Rustarazo ML, Herrera-Aguirre ME, Labra-Barrios ML, Rincon-Limas DE et al (2016) Identification of proteins that are differentially expressed in brains with Alzheimer\u2019s disease using iTRAQ labeling and tandem mass spectrometry. J Proteome 139:103\u2013121","journal-title":"J Proteome"},{"key":"1_CR134","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.3233\/JAD-141266","volume":"43","author":"J Muenchhoff","year":"2015","unstructured":"Muenchhoff J, Poljak A, Song F, Raftery M, Brodaty H, Duncan M et al (2015) Plasma protein profiling of mild cognitive impairment and Alzheimer\u2019s disease across two independent cohorts. J Alzheimers Dis 43:1355\u20131373","journal-title":"J Alzheimers Dis"},{"key":"1_CR135","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1021\/pr401202d","volume":"13","author":"S Musunuri","year":"2014","unstructured":"Musunuri S, Wetterhall M, Ingelsson M, Lannfelt L, Artemenko K, Bergquist J et\u00a0al (2014) Quantification of the brain proteome in Alzheimer\u2019s disease using multiplexed mass spectrometry. J Proteome Res 13:2056\u20132068","journal-title":"J Proteome Res"},{"key":"1_CR136","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.bbr.2016.06.002","volume":"322","author":"SM Neuner","year":"2017","unstructured":"Neuner SM, Wilmott LA, Hoffmann BR, Mozhui K, Kaczorowski CC (2017) Hippocampal proteomics defines pathways associated with memory decline and resilience in normal aging and Alzheimer\u2019s disease mouse models. Behav Brain Res 322:288\u2013298","journal-title":"Behav Brain Res"},{"key":"1_CR137","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3233\/JAD-2007-11203","volume":"11","author":"R Sultana","year":"2007","unstructured":"Sultana R, Boyd-Kimball D, Cai J, Pierce WM, Klein JB, Merchant M et al (2007) Proteomics analysis of the Alzheimer\u2019s disease hippocampal proteome. J Alzheimers Dis 11:153\u2013164","journal-title":"J Alzheimers Dis"},{"key":"1_CR138","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1023\/A:1020941929414","volume":"27","author":"T Tsuji","year":"2002","unstructured":"Tsuji T, Shiozaki A, Kohno R, Yoshizato K, Shimohama S (2002) Proteomic profiling and neurodegeneration in Alzheimer\u2019s disease. Neurochem Res 27:1245\u20131253","journal-title":"Neurochem Res"},{"key":"1_CR139","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s11064-013-1210-1","volume":"39","author":"S Zahid","year":"2014","unstructured":"Zahid S, Oellerich M, Asif AR, Ahmed N (2014) Differential expression of proteins in brain regions of Alzheimer\u2019s disease patients. Neurochem Res 39:208\u2013215","journal-title":"Neurochem Res"},{"key":"1_CR140","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s13361-014-1059-9","volume":"26","author":"L Gu","year":"2015","unstructured":"Gu L, Evans AR, Robinson RAS (2015) Sample multiplexing with cysteine-selective approaches: cysDML and cPILOT. J Am Soc Mass Spectrom 26:615\u2013630","journal-title":"J Am Soc Mass Spectrom"},{"key":"1_CR141","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.nbd.2010.04.011","volume":"39","author":"CD Aluise","year":"2010","unstructured":"Aluise CD, Robinson RAS, Beckett TL, Murphy MP, Cai J, Pierce WM et al (2010) Preclinical Alzheimer disease: brain oxidative stress, A\u03b2 peptide & proteomics. Neurobiol Dis 39:221\u2013228","journal-title":"Neurobiol Dis"},{"key":"1_CR142","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3233\/JAD-2010-101083","volume":"23","author":"CD Aluise","year":"2011","unstructured":"Aluise CD, Robinson RAS, Cai J, Pierce WM, Markesbery WR, Butterfield DA (2011) Redox proteomics analyses of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer\u2019s disease: insights into memory loss in MCI. J Alzheimers Dis 23:257\u2013269","journal-title":"J Alzheimers Dis"},{"key":"1_CR143","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1046\/j.1471-4159.2002.01103.x","volume":"82","author":"A Castegna","year":"2002","unstructured":"Castegna A, Aksenov M, Thongboonkerd V, Klein JB, Pierce WM, Booze R et al (2002) Proteomic identification of oxidatively modified proteins in Alzheimer\u2019s disease brain. Part II: Dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. J Neurochem 82:1524\u20131532","journal-title":"J Neurochem"},{"key":"1_CR144","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1111\/j.1582-4934.2008.00478.x","volume":"13","author":"TT Reed","year":"2009","unstructured":"Reed TT, Pierce WM Jr, Turner DM, Markesbery WR, Butterfield DA (2009) Proteomic identification of nitrated brain proteins in early Alzheimer\u2019s disease inferior parietal lobule. J Cell Mol Med 13:2019\u20132029","journal-title":"J Cell Mol Med"},{"key":"1_CR145","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1002\/pmic.201000523","volume":"11","author":"RAS Robinson","year":"2011","unstructured":"Robinson RAS, Joshi G, Huang Q, Sultana R, Baker AS, Cai J et\u00a0al (2011) Proteomics analysis of brain proteins in APP\/PS-1 human double mutant knock-in mice with increasing amyloid \u03b2-peptide deposition: insights into the effects of in vivo treatment with N-acetylcysteine as a potential therapeutic intervention in mild cognitive impairment and Alzheimer disease. Proteomics 11:4243\u20134256","journal-title":"Proteomics"},{"key":"1_CR146","doi-asserted-by":"publisher","first-page":"180036","DOI":"10.1038\/sdata.2018.36","volume":"5","author":"L Ping","year":"2018","unstructured":"Ping L, Duong DM, Yin L, Gearing M, Lah JJ, Levey AI et al (2018) Global quantitative analysis of the human brain proteome in Alzheimer\u2019s and Parkinson\u2019s disease. Sci Data 5:180036. https:\/\/doi.org\/10.1038\/sdata.2018.36","journal-title":"Sci Data"},{"key":"1_CR147","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.bbapap.2015.01.009","volume":"1854","author":"A Brinkmalm","year":"2015","unstructured":"Brinkmalm A, Portelius E, Ohrfelt A, Brinkmalm G, Andreasson U, Gobom J et\u00a0al (2015) Explorative and targeted neuroproteomics in Alzheimer\u2019s disease. Biochim Biophys Acta 1854:769\u2013778","journal-title":"Biochim Biophys Acta"},{"key":"1_CR148","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1111\/j.1471-4159.2009.06558.x","volume":"112","author":"MA Korolainen","year":"2010","unstructured":"Korolainen MA, Nyman TA, Aittokallio T, Pirttila T (2010) An update on clinical proteomics in Alzheimer\u2019s research. J Neurochem 112:1386\u20131414","journal-title":"J Neurochem"},{"key":"1_CR149","doi-asserted-by":"publisher","first-page":"652","DOI":"10.4088\/JCP.v67n0418","volume":"67","author":"A Papassotiropoulos","year":"2006","unstructured":"Papassotiropoulos A, Fountoulakis M, Dunckley T, Stephan DA, Reiman EM (2006) Genetics, transcriptomics, and proteomics of Alzheimer\u2019s disease. J Clin Psychiatry 67:652\u2013670","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"1_CR150","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.194","volume":"6","author":"RW Paterson","year":"2016","unstructured":"Paterson RW, Heywood WE, Heslegrave AJ, Magdalinou NK, Andreasson U, Sirka E et al (2016) A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer\u2019s disease pathology. Transl Psychiatry 6(11):e952. https:\/\/doi.org\/10.1038\/tp.2016.194","journal-title":"Transl Psychiatry"},{"key":"1_CR151","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13024-015-0059-y","volume":"10","author":"WE Heywood","year":"2015","unstructured":"Heywood WE, Galimberti D, Bliss E, Sirka E, Paterson RW, Magdalinou NK et al (2015) Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay. Mol Neurodegener 10:64. https:\/\/doi.org\/10.1186\/s13024-015-0059-y","journal-title":"Mol Neurodegener"},{"key":"1_CR152","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jprot.2018.04.027","volume":"182","author":"I Begcevic","year":"2018","unstructured":"Begcevic I, Brinc D, Brown M, Martinez-Morillo E, Goldhardt O, Grimmer T et al (2018) Brain-related proteins as potential CSF biomarkers of Alzheimer\u2019s disease: a targeted mass spectrometry approach. J Proteome 182:12\u201320","journal-title":"J Proteome"},{"issue":"1","key":"1_CR153","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/ana.25266","volume":"84","author":"L Yu","year":"2018","unstructured":"Yu L, Petyuk VA, Gaiteri C, Mostafavi S, Young-Pearse T, Shah RC et al (2018) Targeted brain proteomics uncover multiple pathways to Alzheimer\u2019s dementia. Ann Neurol 84(1):78\u201388","journal-title":"Ann Neurol"},{"issue":"1","key":"1_CR154","doi-asserted-by":"publisher","first-page":"1700131","DOI":"10.1002\/prca.201700131","volume":"12","author":"Gunnar Brinkmalm","year":"2017","unstructured":"Brinkmalm G, Sj\u00f6din S, Simonsen AH, Hasselbalch SG, Zetterberg H, Brinkmalm A et al (2018) A parallel reaction monitoring mass spectrometric method for analysis of potential CSF biomarkers for Alzheimer\u2019s disease. Proteomics Clin Appl 12(1). https:\/\/doi.org\/10.1002\/prca.201700131","journal-title":"PROTEOMICS - Clinical Applications"},{"key":"1_CR155","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neuint.2014.05.011","volume":"75","author":"RY Chang","year":"2014","unstructured":"Chang RY, Etheridge N, Dodd PR, Nouwens AS (2014) Targeted quantitative analysis of synaptic proteins in Alzheimer\u2019s disease brain. Neurochem Int 75:66\u201375","journal-title":"Neurochem Int"},{"key":"1_CR156","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1074\/mcp.M116.059915","volume":"15","author":"P Oeckl","year":"2016","unstructured":"Oeckl P, Metzger F, Nagl M, von Arnim CA, Halbgebauer S, Steinacker P et al (2016) Alpha-, beta-, and gamma-synuclein quantification in cerebrospinal fluid by multiple reaction monitoring reveals increased concentrations in Alzheimer\u2019s and Creutzfeldt-Jakob disease but no alteration in synucleinopathies. Mol Cell Proteomics 15:3126\u20133138","journal-title":"Mol Cell Proteomics"},{"issue":"3-4","key":"1_CR157","doi-asserted-by":"publisher","first-page":"1700279","DOI":"10.1002\/pmic.201700279","volume":"18","author":"Julia Dittrich","year":"2018","unstructured":"Dittrich J, Adam M, Maas H, Hecht M, Reinicke M, Ruhaak LR et al (2018) Targeted on-line SPE-LC-MS\/MS assay for the quantitation of 12 apolipoproteins from human blood. Proteomics 18(3\u20134). https:\/\/doi.org\/10.1002\/pmic.201700279","journal-title":"PROTEOMICS"},{"key":"1_CR158","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1750-1326-7-41","volume":"7","author":"J Chen","year":"2012","unstructured":"Chen J, Wang M, Turko IV (2012) Mass spectrometry quantification of clusterin in the human brain. Mol Neurodegener 7:41. https:\/\/doi.org\/10.1186\/1750-1326-7-41","journal-title":"Mol Neurodegener"},{"issue":"7-8","key":"1_CR159","doi-asserted-by":"publisher","first-page":"1600103","DOI":"10.1002\/prca.201600103","volume":"11","author":"Clark M. Henderson","year":"2017","unstructured":"Henderson CM, Bollinger JG, Becker JO, Wallace JM, Laha TJ, MacCoss MJ et al (2017) Quantification by nano liquid chromatography parallel reaction monitoring mass spectrometry of human apolipoprotein A-I, apolipoprotein B, and hemoglobin A1c in dried blood spots. Proteomics Clin Appl 11(7\u20138). https:\/\/doi.org\/10.1002\/prca.201600103","journal-title":"PROTEOMICS - Clinical Applications"},{"key":"1_CR160","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/978-3-7091-6721-2_20","volume":"67","author":"MS Cheon","year":"2003","unstructured":"Cheon MS, Kim SH, Fountoulakis M, Lubec G (2003) Heart type fatty acid binding protein (H-FABP) is decreased in brains of patients with down syndrome and Alzheimer\u2019s disease. J Neural Transm Suppl 67:225\u2013234","journal-title":"J Neural Transm Suppl"},{"key":"1_CR161","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1002\/pmic.201200190","volume":"13","author":"L Ijsselstijn","year":"2013","unstructured":"Ijsselstijn L, Papma JM, Dekker LJ, Calame W, Stingl C, Koudstaal PJ et al (2013) Serum proteomics in amnestic mild cognitive impairment. Proteomics 13:2526\u20132533","journal-title":"Proteomics"},{"key":"1_CR162","doi-asserted-by":"publisher","first-page":"19332","DOI":"10.1038\/srep19332","volume":"6","author":"MA Kennedy","year":"2016","unstructured":"Kennedy MA, Moffat TC, Gable K, Ganesan S, Niewola-Staszkowska K, Johnston A et al (2016) A signaling lipid associated with Alzheimer\u2019s disease promotes mitochondrial dysfunction. Sci Rep 6:19332. https:\/\/doi.org\/10.1038\/srep19332","journal-title":"Sci Rep"},{"key":"1_CR163","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.dadm.2016.09.003","volume":"6","author":"D Li","year":"2017","unstructured":"Li D, Misialek JR, Boerwinkle E, Gottesman RF, Sharrett AR, Mosley TH et al (2017) Prospective associations of plasma phospholipids and mild cognitive impairment\/dementia among African Americans in the ARIC neurocognitive study. Alzheimers Dement (Amst) 6:1\u201310","journal-title":"Alzheimers Dement (Amst)"},{"issue":"1","key":"1_CR164","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13059-017-1215-1","volume":"18","author":"Y Hasin","year":"2017","unstructured":"Hasin Y, Seldin M, Lusis A (2017) Multi-omics approaches to disease. Genome Biol 18(1):83. https:\/\/doi.org\/10.1186\/s13059-017-1215-1","journal-title":"Genome Biol"},{"key":"1_CR165","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.2174\/0929867323666160926150617","volume":"23","author":"B Karahalil","year":"2016","unstructured":"Karahalil B (2016) Overview of systems biology and omics technologies. Curr Med Chem 23:4221\u20134230","journal-title":"Curr Med Chem"},{"key":"1_CR166","doi-asserted-by":"publisher","first-page":"C1","DOI":"10.1152\/ajpcell.00109.2017","volume":"313","author":"SW Pimplikar","year":"2017","unstructured":"Pimplikar SW (2017) Multi-omics and Alzheimer\u2019s disease: a slower but surer path to an efficacious therapy? Am J Physiol Cell Physiol 313:C1\u2013C2","journal-title":"Am J Physiol Cell Physiol"},{"key":"1_CR167","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/B978-0-12-802973-2.00006-9","volume":"138","author":"G Tosto","year":"2016","unstructured":"Tosto G, Reitz C (2016) Use of \u201comics\u201d technologies to dissect neurologic disease. Handb Clin Neurol 138:91\u2013106","journal-title":"Handb Clin Neurol"},{"key":"1_CR168","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13024-016-0095-2","volume":"11","author":"PA Jaeger","year":"2016","unstructured":"Jaeger PA, Lucin KM, Britschgi M, Vardarajan B, Huang R-P, Kirby ED et al (2016) Network-driven plasma proteomics expose molecular changes in the Alzheimer\u2019s brain. Mol Neurodegener 11:31. https:\/\/doi.org\/10.1186\/s13024-016-0095-2","journal-title":"Mol Neurodegener"},{"key":"1_CR169","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.cels.2016.11.006","volume":"4","author":"NT Seyfried","year":"2017","unstructured":"Seyfried NT, Dammer EB, Swarup V, Nandakumar D, Duong DM, Yin L et al (2017) A multi-network approach identifies protein-specific co-expression in asymptomatic and symptomatic Alzheimer\u2019s disease. Cell Syst 4:60\u201372.e4","journal-title":"Cell Syst"},{"issue":"1","key":"1_CR170","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40478-018-0524-2","volume":"6","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, Ma C, Gearing M, Wang PG, Chin LS, Li L (2018) Integrated proteomics and network analysis identifies protein hubs and network alterations in Alzheimer\u2019s disease. Acta Neuropathol Commun 6(1):19. https:\/\/doi.org\/10.1186\/s40478-018-0524-2","journal-title":"Acta Neuropathol Commun"},{"key":"1_CR171","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.neurobiolaging.2013.08.001","volume":"35","author":"L Whiley","year":"2014","unstructured":"Whiley L, Sen A, Heaton J, Proitsi P, Garc\u00eda-G\u00f3mez D, Leung R et al (2014) Evidence of altered phosphatidylcholine metabolism in Alzheimer\u2019s disease. Neurobiol Aging 35:271\u2013278","journal-title":"Neurobiol Aging"},{"key":"1_CR172","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.dadm.2015.05.003","volume":"1","author":"K Klavins","year":"2015","unstructured":"Klavins K, Koal T, Dallmann G, Marksteiner J, Kemmler G, Humpel C (2015) The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer\u2019s disease and mild cognitive impairment. Alzheimers Dement (Amst) 1:295\u2013302","journal-title":"Alzheimers Dement (Amst)"},{"key":"1_CR173","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.dadm.2016.02.008","volume":"3","author":"D Li","year":"2016","unstructured":"Li D, Misialek JR, Boerwinkle E, Gottesman RF, Sharrett AR, Mosley TH et al (2016) Plasma phospholipids and prevalence of mild cognitive impairment and\/or dementia in the ARIC neurocognitive study (ARIC-NCS). Alzheimers Dement (Amst) 3:73\u201382","journal-title":"Alzheimers Dement (Amst)"},{"key":"1_CR174","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.neurobiolaging.2008.03.011","volume":"31","author":"MM Mielke","year":"2010","unstructured":"Mielke MM, Bandaru VVR, Haughey NJ, Rabins PV, Lyketsos CG, Carlson MC (2010) Serum sphingomyelins and ceramides are early predictors of memory impairment. Neurobiol Aging 31:17\u201324","journal-title":"Neurobiol Aging"}],"container-title":["Advances in Experimental Medicine and Biology","Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-05542-4_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T07:29:26Z","timestamp":1606462166000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-05542-4_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030055417","9783030055424"],"references-count":174,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-05542-4_1","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-030-05542-4","asserted-by":"object"}]},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"13 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}